Pliant Therapeutics
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $2,270 |
Gross Profit | -447 | -448 | 1,135 | |
EBITDA | -23,082 | -42,044 | -54,919 | -48,440 |
EBIT | -23,518 | -42,491 | -55,367 | -48,898 |
Net Income | -26,301 | -43,300 | -56,166 | -49,732 |
Net Change In Cash | 0 | 0 | 0 | 2,270 |
Free Cash Flow | -21,081 | -40,715 | -49,126 | -47,871 |
Cash | 93,732 | 86,820 | 91,936 | 71,188 |
Basic Shares | 61,406 | 61,386 | 61,222 | 60,538 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $1,580 | $9,685 | $7,572 |
Gross Profit | -2,125 | 1,580 | 9,685 | 7,572 |
EBITDA | -205,155 | -158,228 | -118,849 | -18,451 |
EBIT | -207,280 | -160,069 | -122,530 | -19,986 |
Net Income | -210,304 | -161,336 | -123,321 | -17,907 |
Net Change In Cash | 0 | 1,580 | 9,685 | 7,572 |
Cost of Revenue | -17,981 | 783 | ||
Free Cash Flow | -159,351 | -117,282 | -96,391 | -77,396 |
Cash | 71,188 | 63,234 | 33,685 | 51,665 |
Basic Shares | 60,538 | 58,719 | 42,015 | 35,846 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0 |
2025-09-30 | -$0.43 |
2025-06-30 | -$0.71 |
2025-03-31 | -$0.92 |
